Medicine recalls
|
| |
| The United States: Pharmacal Issues Nationwide Recall of MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream Due to Microbial Contamination |
| |
The US Food and Drug Administration (FDA) announces that Pharmacal is recalling one lot of MG217 Multi-symptom Treatment Cream & Skin Protectant Eczema Cream, 6oz tube (lot number: 1024088) to the consumer level. The product has been found to be contaminated with Staphylococcus aureus.
Risk Statement: Use of the product could result in a range of infections from localized to severe or life-threatening adverse events. Patients with weakened immune systems or compromised skin — such as those with wounds, burns, or skin disorders — are at increased risk for serious infections, including skin and skin structure infections, infective endocarditis (infection of the heart valves), bone and joint infections, bloodstream infections, and life-threatening conditions like sepsis and septic shock. To date, Pharmacal has not received any reports of adverse events related to this recall.
The product is used as a topical cream and comes in a 6oz tube with product code 5106 and UPC 012277051067.
The affected MG217 Multi-symptom Treatment Cream & Skin Protectant Eczema Cream is lot 1024088 with expiration date of November 2026. The product can be identified by locating the lot number in the crimped end of the tube. MG217 Multi-symptom Treatment Cream & Skin Protectant Eczema Cream was distributed Nationwide to wholesale, retail (HE BUTT Grocery), and internet distributors (Amazon).
The product is used for relief of eczema symptoms.
Please refer to the following website in FDA for details:
http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/pharmacal-issues-nationwide-recall-mg217-multi-symptom-treatment-cream-skin-protectant-eczema-cream
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Wednesday, May 13, 2026
Issued at HKT 18:30
|
| |
